Melanotan II vs MOTS-C
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Melanotan II and MOTS-C (also searched as MOTS-C vs Melanotan II) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Melanotan II centers on skin, while MOTS-C leans toward metabolic. On indexed research, Melanotan II is ahead (Melanotan II: 4 studies, Preclinical; MOTS-C: 3, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Melanotan II is strongest for skin; MOTS-C for metabolic.
- •Evidence: Melanotan II Preclinical (4 studies) vs MOTS-C Human evidence (3).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Synthetic Melanocortin Peptide | Tanning & Sexual Function
Mitochondrial-Derived Peptide | Metabolic Regulator
Melanotan II vs MOTS-C: side-by-side
| Metric | Melanotan II | MOTS-C |
|---|---|---|
| Class | Skin | Longevity |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Preclinical | Human evidence |
| Studies indexed | 4 | 3 |
| Research level | Well Studied | Well Studied |
| Strongest effect | Skin & aesthetics | Metabolic & appetite |
| Healing & recovery | 1.0 | 2.0▲ |
| Muscle & body comp | 0.0 | 1.0▲ |
| Metabolic & appetite | 0.0 | 4.0▲ |
| Neuro & mood | 2.0▲ | 1.0 |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 0.0 | 3.0▲ |
| Skin & aesthetics | 4.0▲ | 0.0 |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Melanotan II | MOTS-C |
|---|---|---|
| Mechanism | Melanocortin-receptor agonist | Mitochondrial-derived peptide; AMPK activation / metabolic regulation |
| Route | Subcutaneous injection (research use) | Subcutaneous injection (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Melanotan II?
### Summary Melanotan II is a synthetic analog of the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (α-MSH), primarily studied for its effects on skin pigmentation and potential therapeutic applications. Research has also explored its impact on mood and stress responses, though caution is advised due to potential side effects and safety concerns.
Full Melanotan II profile, mechanism & studies →What is MOTS-C?
### Summary MOTS-C is a mitochondrial-derived peptide that has garnered attention for its potential roles in metabolic regulation and cellular stress responses. Emerging research suggests it may have implications in various health conditions, including cardiovascular diseases and placental function.
Full MOTS-C profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | MOTS-C | 2.0/5 effect signal |
| Muscle | MOTS-C | 1.0/5 effect signal |
| Metabolic | MOTS-C | 4.0/5 effect signal |
| Neuro | Melanotan II | 2.0/5 effect signal |
| Inflammation | MOTS-C | 3.0/5 effect signal |
| Skin | Melanotan II | 4.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Melanotan II and MOTS-C?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Melanotan II vs MOTS-C: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Melanotan II has 4 approved studies indexed (Preclinical), and MOTS-C has 3 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Melanotan II or MOTS-C better?
It depends on your goal. Melanotan II is strongest for skin; MOTS-C for metabolic. Melanotan II has more indexed studies (4). See the goal-by-goal breakdown above.
Is Melanotan II or MOTS-C better for weight loss?
MOTS-C shows the stronger metabolic & appetite profile (4.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.
Is Melanotan II or MOTS-C better for muscle?
MOTS-C leads on the muscle & body-composition axis (1.0/5).
Which has more research, Melanotan II or MOTS-C?
Melanotan II has 4 approved studies indexed (Preclinical); MOTS-C has 3 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack Melanotan II and MOTS-C?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Melanotan II vs MOTS-C?
Melanotan II: no community-reported effects logged yet. MOTS-C: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Melanotan II or MOTS-C FDA-approved?
Melanotan II is a research-use compound and is not FDA-approved. MOTS-C is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is MOTS-C better than Melanotan II?
For metabolic, MOTS-C has the edge; for skin, Melanotan II does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Melanotan II and MOTS-C are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.